[CBMG] Cellular Biomedicine Group, Inc.


Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 13.5 Change: 0.2 (1.5%)
Ext. hours: Change: 0 (0%)

chart CBMG

Refresh chart

Strongest Trends Summary For CBMG

CBMG is in the long-term up 78% in 2 years and up 38410% in 15 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Cellular Biomedicine Group, Inc., a biomedicine company, develops treatments for cancerous and degenerative diseases in Greater China. The company operates through two segments, Biomedicine and Consulting. It focuses on developing and marketing cell-based therapies to treat serious chronic and degenerative diseases, such as cancer, osteoarthritis, tissue damage, spinal muscular atrophy, various inflammatory diseases, and joint degeneration and metabolic diseases. The company develops treatments utilizing proprietary cell technologies comprising tumor cell specific dendritic cells for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint disease; human umbilical cord-derived mesenchymal progenitor cells; human embryo-derived motor neuron progenitor precursor cells; and human embryo-derived neuronal progenitor precursor cells for the treatment of central nervous system diseases. It also provides consulting services to companies who seek access to the

Fundamental Ratios
Shares Outstanding EPS-1.92 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E-3.7
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-33.34% ROE-36.67% ROI
Current Ratio6.48 Quick Ratio6.42 Long Term Debt/Equity Debt Ratio0.1
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities19.59 M Cash From Investing Activities-750 K Cash From Operating Activities-2.41 M Gross Profit140 K
Net Profit-4.29 M Operating Profit-4.3 M Total Assets57.94 M Total Current Assets32.6 M
Total Current Liabilities5.03 M Total Debt Total Liabilities5.27 M Total Revenue600 K
Technical Data
High 52 week23.65 Low 52 week9.25 Last close12.78 Last change3.23%
RSI18.4 Average true range1.05 Beta0.66 Volume15.97 K
Simple moving average 20 days-18.54% Simple moving average 50 days-31.83% Simple moving average 200 days-32.4%
Performance Data
Performance Week-13.12% Performance Month-29.59% Performance Quart-43.58% Performance Half-33.78%
Performance Year33.13% Performance Year-to-date13.6% Volatility daily4.95% Volatility weekly11.06%
Volatility monthly22.66% Volatility yearly78.5% Relative Volume249.32% Average Volume62.46 K
New High New Low


2019-02-27 18:53:00 | Cellular Biomedicine Group to Present at 8th Annual SVB Leerink Global Healthcare Conference

2019-02-20 08:45:01 | Cellular Biomedicine Group CBMG Reports Q4 Loss, Lags Revenue Estimates

2019-02-19 19:58:00 | Cellular Biomedicine Group Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Progress

2019-02-12 14:20:08 | Should You Be Holding Cellular Biomedicine Group, Inc. NASDAQ:CBMG?

2019-01-17 06:00:00 | Cellular Biomedicine Group's AlloJoin® Therapy for Knee Osteoarthritis KOA Becomes the First Stem Cell Drug Application Approved in China for Phase II Clinical Trials

2019-01-08 19:30:00 | Cellular Biomedicine Group Initiates Patient Recruitment for Clinical Trial in B Cell Maturation Antigen Anti-BCMA Chimeric Antigen Receptor T-Cell CAR-T Therapy Targeting Multiple Myeloma MM

2018-12-26 06:38:38 | What Investors Should Know About Cellular Biomedicine Group, Inc.’s NASDAQ:CBMG Financial Strength

2018-12-18 07:30:00 | Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp as Member of Scientific Advisory Board

2018-11-16 08:50:00 | Investor Expectations to Drive Momentum within ANGI Homeservices, Aytu Bioscience, IRIDEX, Cellular Biomedicine Group, CounterPath, and EXFO — Discovering Underlying Factors of Influence

2018-11-06 09:35:02 | Cellular Biomedicine Group CBMG Reports Q3 Loss, Tops Revenue Estimates

2018-11-06 08:29:30 | Cellular Biomedicine: 3Q Earnings Snapshot

2018-11-06 06:56:34 | Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Business Highlights

2018-11-01 11:28:03 | Earnings Preview: Cellular Biomedicine Group CBMG Q3 Earnings Expected to Decline

2018-10-25 08:56:42 | Cellular Biomedicine Group to Provide Company Cancer Immunotherapy Pipeline Update and Facility Tour for Attendees of the Advanced Cell Therapy Summit in Shanghai

2018-09-27 14:41:27 | [$$] Cellular Biomedicine, Novartis in CAR-T Cell Therapy Pact

2018-09-27 13:34:13 | Novartis strikes deal with Chinese firm to make Kymriah

2018-09-27 07:30:00 | Cellular Biomedicine Group Enters Into Strategic Licensing and Collaboration Agreement with a Global Leader in CAR-T Cell Therapy for Patients in China

2018-09-24 15:30:05 | Who Are The Top Investors In Cellular Biomedicine Group Inc NASDAQ:CBMG?

2018-09-24 08:15:29 | Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference

2018-08-28 09:16:20 | Cellular Biomedicine Group to Present on Three Panels at B. Riley FBR Annual Healthcare Conference

2018-08-08 08:50:12 | Cellular Biomedicine Group CBMG Reports Q2 Loss, Tops Revenue Estimates

2018-08-08 07:46:19 | Cellular Biomedicine: 2Q Earnings Snapshot

2018-08-08 07:31:01 | Cellular Biomedicine Group Reports Second Quarter and First Half 2018 Financial Results and Business Highlights

2018-07-20 09:30:00 | Stem-Cell Investments on the Rise

2018-06-22 09:00:00 | Cellular Biomedicine Group Announces Grand Opening of Global Research and Development Center in Gaithersburg, Maryland

2018-06-21 07:30:00 | Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Summit Asia

2018-05-08 06:00:00 | Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress

2018-05-08 05:08:31 | Cellular Biomedicine: 1Q Earnings Snapshot

2018-05-07 10:51:19 | Should You Be Content With Cellular Biomedicine Group Inc’s NASDAQ:CBMG Earnings Growth?

2018-04-30 08:30:00 | Cellular Biomedicine Group Announces Results of 2018 Annual Meeting of Stockholders

2018-03-23 07:00:00 | Cellular Biomedicine Group CBMG Announces Annual Meeting of Stockholders

2018-03-20 07:40:00 | Wired News – Cellular Biomedicine's 48-Week Data off China-based Phase-I Clinical Trial Shows Positive Result for AlloJoinTM for Treatment of KOA

2018-03-16 07:00:00 | Cellular Biomedicine Group Announces Positive 48-Week Clinical Data of AlloJoin™ Human Adipose-Derived Mesenchymal Progenitor Cell haMPC Knee Osteoarthritis KOA China Phase I Trial

2018-03-06 09:44:18 | Cellular Biomedicine reports 4Q loss

2018-03-06 09:27:40 | Cellular Biomedicine Group Reports Full-Year 2017 Financial Results and Recent Operational Progress

2018-03-01 09:15:18 | Cellular Biomedicine Group Invited to Present a Keynote Speech at Phar-East Asia Pharma & Biotech Festival

2018-02-05 08:18:00 | Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.

2018-01-19 20:43:09 | CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution 

2018-01-18 16:15:00 | CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution 

2017-12-28 11:55:16 | ETFs with exposure to Cellular Biomedicine Group, Inc. : December 28, 2017

2017-12-28 07:30:00 | Cellular Biomedicine Group Announces Closing of $14.5 Million Private Placement Offering

2017-12-27 08:46:56 | Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017

2017-11-09 08:45:46 | Cellular Biomedicine reports 3Q loss

2017-11-09 08:30:24 | Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational Highlights

2017-11-07 06:00:00 | Cellular Biomedicine Group Opens its New Shanghai GMP Facility and Joint Laboratory

2017-11-06 07:20:06 | Thermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic Partnership to Develop Manufacturing Processes

2017-10-31 08:00:00 | Cellular Biomedicine Group Executives to Present at Biotech and Money World HealthEx Forum in London

2017-09-22 08:40:00 | Cellular Biomedicine Group Plans Grand Opening of its New Shanghai Facility

2017-09-20 13:51:20 | One Thing To Consider Before Buying Cellular Biomedicine Group Inc CBMG

2017-09-19 06:30:00 | BioLife Solutions CryoStor® Cell Freeze Media Embedded in Cellular Biomedicine Group Clinical Trial of AlloJoin™